Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

UCB Pharma Limited
208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 14/07/2008
SPC Elantan LA25

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/07/2008 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
  • Change to section 6. 3 - Shelf Life
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Company name change or merger
Date of revision of text on the SPC:   28-Feb-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Shelf-life extended to 5 years.
Updated to reflect change of ownership from Schwarz Pharma Ltd to UCB Pharma Ltd.
Updated on 13/09/2007 and displayed until 14/07/2008
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   09/2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 9: Date changed to 07 September 2007
Section 10: Date changed to September 2007
Updated on 27/09/2006 and displayed until 13/09/2007
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   07/2006
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company
Section 7 (MA Holder) - New address added: SCHWARZ PHARMA Limited, 5 Hercules Way, Leavesden Park, Watford, WD25 7GS, United Kingdom.
 
Section 10 (Date of revision of text) - New date added: July 2006
Updated on 23/01/2006 and displayed until 27/09/2006
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
Updated on 20/01/2006 and displayed until 23/01/2006
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
Updated on 22/12/2005 and displayed until 20/01/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 02/11/2005 and displayed until 22/12/2005
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Correction of spelling/typing errors
Updated on 01/11/2005 and displayed until 02/11/2005
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
  • Change to section 4.9 - Overdose
  • Change to section 10 (date of (partial) revision of the text
Updated on 22/06/2005 and displayed until 01/11/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 15/06/2005 and displayed until 22/06/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 02/06/2005 and displayed until 15/06/2005
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
  • Change to section 4.8 - Undesirable Effects
Updated on 05/02/2003 and displayed until 02/06/2005
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Updated on 09/01/2003 and displayed until 05/02/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 26/09/2002 and displayed until 09/01/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 31/07/2002 and displayed until 26/09/2002
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
  • Change to section 6.1 - List of Excipients
  • Change to section 10 (date of (partial) revision of the text
Updated on 03/08/2001 and displayed until 31/07/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors

Active Ingredients/Generics

 
  isosorbide mononitrate